Log In
BCIQ
Print this Print this
 

Tuzistra XR, codeine polistirex/chlorpheniramine polistirex (CCP-01)

  Manage Alerts
Collapse Summary General Information
Company Tris Pharma Inc.
DescriptionExtended-release formulation of codeine, a semisynthetic narcotic antitussive and analgesic, and chlorpheniramine, a histamine H1 receptor (HRH1) antagonist
Molecular Target Histamine H1 receptor (HRH1)
Mechanism of ActionHistamine H1 receptor antagonist; Opioid receptor agonist
Therapeutic ModalitySmall molecule: Combination
Latest Stage of DevelopmentMarketed
Standard IndicationCough
Indication DetailsAcute treatment of cough and cold; Treat cough and cold
Regulatory Designation U.S. - Standard Review (Treat cough and cold)
PartnerVernalis plc

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

$89.0M

$5.0M

$84.0M


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

02/10/2012

$89.0M

$5.0M

$84.0M

Get a free BioCentury trial today